Full donor chimerism by day 30 after allogeneic peripheral blood progenitor cell transplantation is associated with a low risk of relapse in pediatric patients with hematological malignancies

Leukemia

Volumn 19, Issue 4, 2005, Pages 504-506

  Lassaletta, A ^a   Ramirez M ^a   Montero, J M ^a   Gonzalez Vicent M ^a   Balas, A ^b   Madero, L ^a   Diaz M A ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^b Ctr Trasfusion Comunidad de Madrid ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLOSPORIN A; GENOMIC DNA; METHOTREXATE;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; APHERESIS; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DONOR; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFORMED CONSENT; LEUKEMIA; MALE; MULTIVARIATE ANALYSIS; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SKIN BIOPSY; STEM CELL MOBILIZATION; TANDEM REPEAT; WHOLE BODY RADIATION;

EID: 17144361803     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403692     Document Type: Article

References (9)

1. Valcarcel D, Martino R, Caballero D, Mateos MV, Perez-Simon JA, Canals C et al. Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant 2003; 31: 387-392.
2. Briones J, Urbano-Ispizua A, Lawler M, Rozman C, Gardiner N, Marin P et al. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells. Exp Hematol 1998; 26: 415-420.
3. Dubovsky J, Daxberger H, Fritsch G, Printz D, Peters C, Matthes S et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection. Leukemia 1999; 13: 2060-2069.
4. Diaz MA, Sevilla J, de la Rubia J, Verdeguer A, Espigado I, Vicent MG et al. Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation. Haematologica 2003; 88: 919-922.
5. Bader P, Niethammer D, Willasch A, Kreyenberg H, Klingebiel T. How and when should we monitor chimerism after allogeneic stem cell transplantation? Bone Marrow Transplant 2005; 35: 107-119.
6. Barrios M, Jimenez-Velasco A, Roman-Gomez J, Madrigal ME, Castillejo JA, Torres A et al. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia. Haematologica 2003; 88: 801-810.
7. Brunet S, Urbano-Ispizua A, Ojeda E, Ruiz D, Moraleda JM, Diaz MA et al. Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies. Br J Haematol 2001; 114: 544-550.
8. Korbling M, Anderlini P. Peripheral blood stem cell versus bone marrow transplantation: does the source of hematopoietic stem cells matter? Blood 2001; 98: 2900-2908.
9. Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175-181.